Analog Devices CEO exercises options, sells 10K shares
Analog Devices Chair & CEO Vincent Roche exercised stock options and sold shares in a planned transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Analog Devices Chair & CEO Vincent Roche exercised stock options and sold shares in a planned transaction. On May 1, 2026, he exercised 10,000 non-qualified stock options for common stock at $94.41 per share and received 10,000 shares of Analog Devices common stock.
The same day, he sold 10,000 common shares in an open-market transaction at an average price of $397.91 per share, pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2025. After these transactions, Roche holds about 187,537.875 shares directly and 23,515 shares indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,000 shares ($3.04M approx. pre-tax spread)
Exercise and Sale
4 txns
Insider
ROCHE VINCENT
Role
Chair & CEO
Sold
10,000 shs ($3.98M)
Approx. gross sale proceeds
$3.98M
Approx. exercise cost
$944K
Approx. pre-tax spread
$3.04M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 10,000 | $94.41 | $944K |
| Exercise | Comm Stock - $.16-2/3 value | 10,000 | $94.41 | $944K |
| Sale | Comm Stock - $.16-2/3 value | 10,000 | $397.91 | $3.98M |
| holding | Comm Stock-$.16-2/3 value | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 14,637 contracts (Direct);
Comm Stock - $.16-2/3 value — 187,537.875 shares (Direct);
Comm Stock-$.16-2/3 value — 23,515 shares (Indirect, Vincent Roche 2024 Grantor Retained Annuity Trust)
Footnotes (3)
- F1. These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on May 23, 2025.
- F2. Shares held by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.
- F3. This option is fully vested.
Key Figures
Shares sold: 10,000 shares
Sale price per share: $397.91 per share
Option exercise price: $94.41 per share
+3 more
6 metrics
Shares sold
10,000 shares
Open-market sale of common stock on May 1, 2026
Sale price per share
$397.91 per share
Average price for 10,000 common shares sold
Option exercise price
$94.41 per share
Non-qualified stock options exercised for 10,000 shares
Direct holdings after transactions
187,537.875 shares
Common stock directly owned by Roche after May 1, 2026
Indirect trust holdings
23,515 shares
Shares held by Vincent Roche 2024 Grantor Retained Annuity Trust
Net share change from buy/sell
-10,000 shares
Net of open-market sale relative to exercises and other trades
Key Terms
Rule 10b5-1 trading plan, Non-Qualified Stock Option, Grantor Retained Annuity Trust, open-market sale, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
Grantor Retained Annuity Trust financial
"Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024"
A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.
open-market sale financial
"Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative exercise/conversion financial
"transaction_action: derivative exercise/conversion"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did ADI CEO Vincent Roche report on this Form 4?
Vincent Roche reported exercising 10,000 non-qualified stock options at $94.41 per share, then selling 10,000 Analog Devices common shares at $397.91 per share, both dated May 1, 2026, leaving him with substantial remaining direct and indirect holdings.
What options did the ADI CEO exercise in this Form 4 filing?
He exercised 10,000 non-qualified stock options with a $94.41 per share exercise price, converting them into 10,000 shares of Analog Devices common stock. The filing notes this option grant is fully vested, and the exercise occurred on May 1, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
